432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a melanoma
oleh: Merrick Ross, Reinhard Dummer, Lev Demidov, Edward Chan, David Gyorki, Robert Conry, Hoi-Shen Radcliffe
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.